Eli Lilly
Leader in metabolic disease and oncology
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Obesity
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)Phase 3 · Recruiting · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingPhase 3 · Recruiting · Diabetes Mellitus, Type 2
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)Phase 3 · Recruiting · Obesity
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPhase 3 · Recruiting · Carcinoma, Non-Small-Cell Lung
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Phase 3 · Recruiting · Type 2 Diabetes
Selected patent records
tirzepatide · Expires 2036-05-13
US 11357820tirzepatide · Expires 2039-06-14
US 11918623tirzepatide · Expires 2039-06-14
US 12453756tirzepatide · Expires 2039-06-14
US 12629404tirzepatide · Expires 2039-06-14
US 12453755tirzepatide · Expires 2039-06-14
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/eli-lilly/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.